Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System
Clinical trial NCT05753384 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05753384
- Sponsor
- Poitiers University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2028-12-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.